Grants for Public housing authorities - Federal

This funding opportunity provides financial support to national and nonprofit organizations to enhance training and technical assistance for professionals addressing domestic violence, sexual assault, and stalking across the United States.

This funding opportunity supports institutions in creating collaborative training networks for early-career researchers focused on advancing studies in kidney, urologic, and hematologic diseases.

This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants will support innovative studies designed to investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development and testing of new methodologies and models, and (3) secondary data analyses. This FOA is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can expand available resources and tools, such as biospecimens, patient derived models, and methods that are necessary to conduct basic research in cancer health disparities.

This funding opportunity supports researchers exploring the causes and effects of mood and psychotic disorders during menopause, aiming to improve mental health interventions for women experiencing this transition.

This grant provides funding to support the career development of underrepresented clinical scientists in cancer research, helping them gain the skills and experience needed to advance in their field.

This funding opportunity provides substantial financial support to higher education institutions and nonprofit organizations to establish collaborative centers that advance research and resources for HIV/AIDS.

The purpose of this notice of funding opportunity (NOFO) is to enhance the participation of individuals from nationally underrepresented backgrounds to enhance the participation of individuals from nationally underrepresented backgrounds in cardiovascular, pulmonary, hematologic and sleep disorders research across the career development continuum by providing support to institutions that promote diversity. The NHLBI's T32 Training Program for Institutions That Promote Diversity is a Ruth L. Kirschstein National Research Service Award Program intended to support training of predoctoral and health professional students and individuals in postdoctoral training institutions with an institutional mission focused on serving health disparity populations not well represented in scientific research, or institutions that have been identified by federal legislation as having an institutional mission focused on these populations, with the potential to develop meritorious training programs in cardiovascular, pulmonary, and hematologic diseases, and sleep disorders. These institutions are uniquely positioned to engage minority and other health disparity populations in research, translation, and implementation of research advances that impact health outcomes, as well as provide health care for these populations.This NOFO does not allow appointed trainees to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.

The NIH Research Education Program (R25) is a grant that supports educational activities, including courses for skills development, research experiences, and mentoring activities, aimed at enhancing the training of a diverse workforce for biomedical, behavioral, and clinical research needs, with a focus on responsible conduct and diversity enhancement.

Grant Title: Co-infection and Cancer (R01 Clinical Trial Not Allowed) - This grant aims to improve our understanding of how co-infections (excluding HIV) contribute to cancer, particularly in under-studied populations, to identify new prevention and treatment strategies.

This grant provides funding for researchers to conduct innovative analyses of existing data to better understand substance use disorders and related behaviors, particularly focusing on vulnerable populations and the effectiveness of interventions.

This funding opportunity supports researchers in the field of clinical neurosciences to conduct studies that compare the effectiveness of various preventive, diagnostic, and therapeutic strategies for neurological disorders.

This funding opportunity provides support for researchers to plan and implement clinical trials focused on developing and testing behavioral and social interventions for dental, oral, or craniofacial health issues.

This funding opportunity provides financial support for small-scale research projects that investigate the ethical, legal, and social challenges arising from advancements in human genetic and genomic research.

This funding opportunity provides financial support to organizations that improve legal assistance for older adults facing economic and social challenges, particularly in underserved communities.

This funding opportunity is designed to support community-based projects that aim to reduce health disparities in chronic kidney disease among underserved populations by addressing social determinants of health.

This funding opportunity provides financial support for research and development projects aimed at improving algal systems for biofuels and bioproducts, targeting technical challenges and promoting sustainable energy solutions.

This funding opportunity supports innovative research projects that aim to improve the use of genomic information in clinical care, particularly for diverse populations, with a focus on health outcomes and addressing disparities.

This funding opportunity provides financial support for various organizations to research and improve reflective supervision practices in early childhood home visiting programs, ultimately enhancing service quality and outcomes for families.

This notice of funding opportuntity (NOFO) encourages applications for investigator-initiated multi site clinical trials (e.g., efficacy, effectiveness, or pragmatic trials) to study the effects of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions), and/or multicomponent interventions that include physical, psychological, and/or nutritional approaches in NCCIH- designated areas of high research priority. Clinical Coordinating Centers (CCC) should develop and implement the proposed fully powered multi-site clinical trial (Phase III and beyond). The objective of a CCC application is to present the scientific rationale and a comprehensive scientific and operational plan for the clinical trial. CCCapplications are expected to describe plans for project management, participant recruitment and retention strategies, performance milestones, scientific conduct, and dissemination of results. CCC applications submitted under this NOFO will utilize a two-phase, milestone-driven cooperative agreement (UG3/UH3) funding mechanism. In addition, an accompanying Data Coordinating Center (DCC) application (U24), submitted under PAR-24-087 proposing a data analysis and data management plan for the clinical project is required. Both a CCC application and a corresponding DCC application need to be submitted simultaneously for consideration by NCCIH. For additional information about the mission, strategic vision, and research priorities of NCCIH, applicants are encouraged to consult the NCCIH website: (https://nccih.nih.gov/about/plans). Applicants are encouraged to contact the appropriate Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this NOFO.

This funding opportunity provides financial support to early-career researchers in the fields of arthritis, musculoskeletal, and skin diseases, helping them conduct small-scale studies as they transition to independent investigator roles.